Margaret Ancona, Senior VP at Myriad Genetics Inc, sold 11,538 shares, now owning 79,366. Myriad Genetics specializes in genetic testing, aiding healthcare decisions. Ancona's sale reflects insider activity, offering investors a view on the company's valuation and future.